HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ashutosh Arun Selected Research

O-methylmurrayamine A

9/2017Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ashutosh Arun Research Topics

Disease

5Infections
01/2023 - 07/2020
4Neoplasms (Cancer)
02/2021 - 04/2016
4Breast Neoplasms (Breast Cancer)
04/2019 - 06/2015
3Communicable Diseases (Infectious Diseases)
01/2023 - 12/2020
2Parasitic Diseases (Parasitic Disease)
01/2023 - 01/2022
2Cardiomyopathies (Cardiomyopathy)
01/2023 - 02/2021
1Chagas Disease (American Trypanosomiasis)
07/2020
1Body Weight (Weight, Body)
04/2019
1Colonic Neoplasms (Colon Cancer)
09/2017
1Necrosis
06/2015

Drug/Important Bio-Agent (IBA)

4Piwi-Interacting RNAIBA
01/2023 - 12/2020
2Biomarkers (Surrogate Marker)IBA
01/2023 - 12/2020
2TubulinIBA
04/2019 - 01/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2017 - 01/2016
2TamoxifenFDA LinkGeneric
04/2016 - 06/2015
1RNA (Ribonucleic Acid)IBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
12/2022
1CateninsIBA
01/2022
1Small Untranslated RNAIBA
12/2020
1Nuclear Proteins (Protein, Nuclear)IBA
07/2020
1Thrombospondin 1IBA
07/2020
1carbazoleIBA
04/2019
1murrayazolineIBA
09/2017
1O-methylmurrayamine AIBA
09/2017
1AntioxidantsIBA
09/2017
1AlkaloidsIBA
09/2017
1LigandsIBA
04/2016
1Estradiol (Delestrogen)FDA LinkGeneric
04/2016
1Estrogen ReceptorsIBA
06/2015
1FITC-annexin A5IBA
06/2015
1Estrogens (Estrogen)FDA Link
06/2015
1afimoxifene (hydroxytamoxifen)IBA
06/2015

Therapy/Procedure

3Therapeutics
12/2022 - 04/2016
1Oral Administration
04/2019